Search Results - "Mareev, Yu. V."

Refine Results
  1. 1

    Role of anticoagulants in therapy and prevention of recurrent venous thromboembolism in patients with cancer: a meta-analysis of randomized trials with apixaban by Mareev, V Yu, Mareev, Yu V

    Published in Kardiologiia (31-03-2022)
    “…Background    Venous thromboembolic complications (VTEC) are a major non-oncological cause of death of patients with malignant neoplasm (MNP). This determines…”
    Get more information
    Journal Article
  2. 2

    The ability of modern therapy to improve the prognosis of patients with HF: role of angiotensin neprilysin inhibitors and sodium-glucose cotransporter inhibitors by Mareev, Yu V, Mareev, V Yu

    Published in Kardiologiia (01-07-2021)
    “…Major principles for treatment of chronic heart failure with reduced left ventricular ejection fraction <40% (HFrEF) include a "triple neurohormonal blockade"…”
    Get more information
    Journal Article
  3. 3
  4. 4

    Modern approaches to interpretation of clinical trial results to evaluate the effectiveness of heart failure therapy. Analysis of the results of randomized trials PARADIGM-HF, DAPA-HF, EMPEROR-Reduced and VICTORIA by Gilyarevsky, S. R., Mareev, Yu. V.

    Published in Rossiĭskiĭ kardiologicheskiĭ zhurnal (01-06-2023)
    “…The article discusses the results of modern studies evaluating the effectiveness of drug therapy for heart failure with reduced ejection fraction (HFrEF)…”
    Get full text
    Journal Article
  5. 5

    Influence of Omega-3 PUFA on Non-invasive factors determining the risk of arrhYthmias eXcess and sudden cardiac death in patients with HFpEF with ischemic etiology (ONYX) by Mareev, V Yu, Mareev, Yu V

    Published in Kardiologiia (12-11-2020)
    “…Aim Patients with heart failure with reduced left ventricular (LV) ejection fraction (HFrEF) who have had acute myocardial infarction have an unfavorable…”
    Get more information
    Journal Article
  6. 6

    Role of age, comorbidity and renin- angiotensin-aldosterone system in COVID-19. Effects of ACE inhibitors and angiotensin receptor blockers by Mareev, Yu V, Mareev, V Yu

    Published in Kardiologiia (08-04-2020)
    “…The review addressed the relationship of coronavirus disease 2019 (COVID-19) with functioning of the renin-angiotensin-aldosterone axis and the causes for…”
    Get more information
    Journal Article
  7. 7

    How evaluate results of treatment in patients with COVID-19? Symptomatic Hospital and Outpatient Clinical Scale for COVID-19 (SHOCS-COVID) by Mareev, V Yu, Begrambekova, Yu L, Mareev, Yu V

    Published in Kardiologiia (05-12-2020)
    “…Aim Development of a novel scale for assessing medical state in patients with new coronavirus infection based on clinical and laboratory disease severity's…”
    Get more information
    Journal Article
  8. 8

    Chronic Heart Failure in Patients Hospitalized in 2002 and 2021: Comparative Analysis of Prevalence, Clinical Course and Drug Therapy by Garganeeva, A A, Tukish, O V, Vitt, K N, Mareev, Yu V, Kuzheleva, E A, Ryabov, V V, Kondratiev, M Yu, Syromyatnikova, E E, Dorzhieva, B B, Mareev, V Yu

    Published in Kardiologiia (31-03-2024)
    “…Comparative analysis of the prevalence of chronic heart failure (CHF), clinical and medical history data, and drug therapy of patients admitted to a cardiology…”
    Get more information
    Journal Article
  9. 9

    Cardiac contractility modulation in heart failure with reduced ejection fraction treatment by Chugunov, I A, Mareev, Yu V, Fudim, M, Mironova, N A, Mareev, V Yu, Davtyan, R V

    Published in Kardiologiia (30-11-2022)
    “…Heart failure with reduced left ventricular ejection fraction (LV EF) (HFrEF) is a significant issue of health care due to increasing indexes of morbidity and…”
    Get more information
    Journal Article
  10. 10
  11. 11

    Difficulties in diagnosis of heart failure with preserved ejection fraction in clinical practice: dissonance between echocardiography, NTproBNP and H2HFPEF score by Mareev, Yu V, Garganeeva, A A, Tukish, O V, Rebrova, T Yu, Anikina, D V, Mareev, V Yu

    Published in Kardiologiia (12-11-2019)
    “…This pilot study was aimed to assess the percentage of patients admitted to a Russian hospital and diagnosed with heart failure with preserved ejection…”
    Get more information
    Journal Article
  12. 12

    Prospects for use of Vericiguat in HFrEF: Implications of VICTORIA Trial Results. Advisory Board Summary by Belenkov, Yu N, Arutyunov, G P, Mareev, V Yu, Koziolova, N A, Sitnikova, M Yu, Ageev, F T, Gilyarevsky, S R, Chesnikova, A I, Yakushin, S S, Perepech, N B, Mareev, Yu V

    Published in Kardiologiia (01-05-2023)
    “…In September 2021, an online meeting of the Council of Experts was held. The proposed focus of discussion was publishing the results of an international…”
    Get more information
    Journal Article
  13. 13
  14. 14
  15. 15

    Hydroxychloroquine in patients with novel coronavirus infection (COVID-19): a case-control study by Kamalov, A A, Mareev, V Yu, Orlova, Ya A, Plisyk, A G, Akopyan, Z A, Mareev, Yu V, Mershina, E A, Begrambekova, Yu L, Pakhomov, P V

    Published in Kardiologiia (02-03-2021)
    “…Actuality One of the most widely discussed treatments for patients with COVID-19, especially at the beginning of the epidemy, was the use of the antimalarial…”
    Get more information
    Journal Article
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20